from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1088/PE9

LFCtreatmentdescriptionclass of inhibitor

0.363

Amikacinug/mL Amikacintranslation

1.171

Cap5-10ug/mL Capreomycintranslation

1.301

Rox10-50 ug/mL Roxithromycintranslation

-0.333

SM2-5 ug/mL Streptomycintranslation

1.607

Tet5-10 ug/mL Tetracyclinetranslation

0.643

Rif0.2-5ug/mL Rifampicintranscription

-0.851

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.684

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.848

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.203

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.490

Clofazimine10-13 ug/mL Clofaziminerespiration

0.563

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.204

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.430

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.215

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.984

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.726

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.816

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.424

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.113

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.113

KCN5-20 ug/mL Potassium cyaniderespiration

1.374

NaN30.2-2 mM Sodium aziderespiration

-0.739

Nigericin50 uM Nigericinrespiration

0.225

TRC10-150 ug/mL Triclosanrespiration

-0.368

TRZ10-25 ug/mL Thioridazinerespiration

0.205

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.326

menadione6-10 ug/mL Menadionerespiration

0.983

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.009

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.598

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.003

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.382

NRP_1Non-replicating persistence stage 1dosRassociated

-0.601

Amp0.2mg/mL AmpicillincellWall

-0.724

Cephalexin20-100 ug/mL CephalexincellWall

-0.338

Cerulenin0.32-5 ug/mL CerulenincellWall

0.462

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.180

EMB10-20 ug/mL EthambutolcellWall

-0.444

Eta12-40 ug/mL EthionamidecellWall

-0.139

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.361

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.190

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.636

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.399

BZA0.12 mg/mL BenzamidearomaticAmides

0.420

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.558

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.086

H2O24 mM hydrogen peroxideDNAdamaging

0.019

Levo10 ug/mL LevofloxacinDNAdamaging

-0.894

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.321

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.483

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.487

UVUV-irradiationDNAdamaging

-0.057

ARP41-4 ug/mL Antitubercular compound ARP4?

0.082

Antimycin12.5-50 ug/mL Antimycin A?

-0.571

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.132

PA_110-50 ug/mL Antitubercular compound PA-1?

0.083

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.581

PA8240.2-2 ug/mL PA-824?

0.027

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.112

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.109

Verapamil50 uM Verapamil?

-0.097

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.875

methoxatin10-20 ug/mL Methoxatin?